Charles Potter

Mr. Potter has over 27 years experience in applied systems design in a variety of diverse fields. For the past sixteen years Mr. Potter has been developing advanced informatics solutions in cancer research and biomedical informatics at Strang Cancer Prevention Center, Weill Medical College of Cornell and Memorial Sloan-Kettering Cancer Center. Prior to joining Strang Cancer Prevention Center he worked for IBM TJ Watson Research Center, Juilliard, Rockwell International and the US Air Force.

His work on large-scale cancer systems at Strang was inducted into the Permenant Research Collection of the Smithsonian Institution in 1998. In 1997 he was nominated for a Computerworld Smithsonian award by Bill Gates. In 1996 he won the Windows World Open in Business Intelligence Systems In 1995 he was a finalist in the Uniforum Open Awards in Bio-Technology and finalist in Windows World Open in Healthcare.

He is a member of Institute of Electrical and Electronics Engineers, New York Academy of Sciences, American Medical Informatics Association, Microsoft Developer Network, Healthcare Information and Management Systems Society and The College of Healthcare Information Management Executives.

RESEARCH INTERESTS

Two computing architectures were invented at Strang and are used to study methods of reconciling diverse and often contradictory results of individualized cancer risk evaluations when multiple models of cancer risk are used. Object Class Networks (OCNs) were developed to provide a software architecture for calculation of breast cancer risk using the Gail and Claus models. Limitations in the ability of the class architecture to modify itself in order to account for exceptions in the Gail and Claus models required the extension of OCNs to include techniques from computational genetic algorithms. Genetic Object Class Networks (GOCNs) integrate genetic algorithms with OCNs and produced an object class architecture which has the ability to modify itself based upon generative patterns developed during the use of the software.

The modification of the software through specialized transformation objects without the direct intervention of a human programmer, may in the future, provide a powerful method of intelligent data collection and analysis which is reflective of the complex etiology of cancer.

KEYWORDS: HL7, medical Informatics, bioinformatics, cancer risk assessment, genetic algorithms, neural networks.

AWARDS

2003 Golden Web Award 2003 International Association of Web Masters and Designers
2003 Golden Web Award 2002 International Association of Web Masters and Designers
1998 Genetics Outreach System 2.0 inducted into the Smithsonian Institution
1997 Computerworld Smithsonian Laureate, Nominated by Bill Gates
1996 Winner, Microsoft Windows World Open Software Competition Business Intelligence Systems
1995 Finalist, Windows World Open Software Competition Healthcare, Computerworld/Windows World 1995 Finalist, Uniforum Open Software Competition Healthcare/Bio-Technology, InfoWeek 1995
1983 National Endowment Arts, Grants in Composition
1980-81 Electronic Music Fellow, The Juilliard School
1979-80 Electronic Music Fellow, The Juilliard School
1979 National Endowment for the Arts, Meet The Composer Grant
1978 National Endowment for the Arts, Meet The Composer Grant
1978 American Music Center (MB Rockefeller & NEA)

PROFESSIONAL AFFILIATIONS

New York Academy of the Sciences
American Medical Informatics Association
College of Healthcare Information Management Executives
Healthcare Information and Management Systems Society
Institute of Electrical and Electronics Engineers
Microsoft Developer Network
Association for Computing Machinery
Microsoft Health Care Users Group
International Webmasters Association
ACM SIGBIO (Biomedical Computing)
ACM SIGART (Artificial Intelligence)
ACM SIGACT (Algorithms and Computation Theory)

PUBLICATIONS

1. Carter BJ, Birnbaum AS, Hark L, Vickery B, Potter C, Osborne MP, Using media messaging to promote healthful eating and physical activity among urban youth. Journal of Nutrition and Behavior: 2005. 37:2, 98-99

2. Potter Charles E., James G. Beldock, 1997, Genetic object class networks (GOCN): Transformational modeling of breast cancer risk and family history data. Annals of New York Academy of Sciences., 833: 164-168

3. James G. Beldock, Potter Charles E,,1997, Physician and counselor tailored hybrid computer interfaces for cancer genetics risk analysis software. Annals of New York Academy of Sciences, 833: 154-163

4. Singhal Hemant, Potter Charles E. , Osborne Michael P., 1997, No effect of timing of biopsy in the menstrual cycle on incidence of bone marrow micrometastasis in patients with breast cancer. Annals of Surgical Oncology, 4:503-504

5. Potter Charles E, James G. Beldock, 1996, Model scope, analysis reconciliation and report flexibility limitations of the Strang Breast Cancer Risk Evaluator. Presentation Strang International Cancer Prevention Conference, Rockefeller University New York

6. Potter CE, Beldock JG, Rosenthal G, Osborne MP. 1995, A clinical friendly computer program for calculating breast cancer risk using the gail and claus models. Annals of the New York Academy of Sciences; 768:301

7. Potter CE, Beldock JG. 1995 Object class networks for interface-independent calculation with gail and claus models. Annals of New York Academy of Sciences, 1995, 768:308-311 .

8. Potter CE, Wu V, Woo D, Wong G. 1995, Strang national high risk registry (NHRR) database: systems and data normalization for long-term data management. Proceedings of Society of Clinical Trials, 3:120

9. Singhal H, Cote RJ, Potter C, Osborne MP. 1994, Bone marrow micrometastases (BMM) in breast cancer: relationship to local-regional disease status. Proceedings of American Society of Clinical Oncology;13:215

10. Singhal H, Tiwari R, Hoda S, Li G, Potter C, Osborne MP. 1994 Association of bone marrow micrometastases, an early marker of relapse, with mutant p53 overexpression. Proceedings Surgical Oncology and Associated Immunology, 75-76

11. Potter CE, Beldock JG, Osborne MP, Rosenthal G. 1994 A computer program evaluates the risk of breast cancer for use by genetic counselors. Proceedings American Society for Human Genetics

12. Osborne MP, Cote RJ, Wong GY, Gonzalez A, Potter C, Vlamis V, Rosen PP. 1993, Bone marrow micronmetastases (BMM) in breast cancer: The effect of systemic tumor cell (TC) burden on early relapse. Proceedings of the American Society of Clinical Oncology;12:102

13. Osborne MP, Potter CE, Borgen PI, Wong GY, Lubin MB, Miller DG. 1992 Surveillance programs for women at increased risk of breast cancer due to a family history in first degree relatives. Proceedings of the American Society of Clinical Oncology;11:147

14. Osborne MP, Cote RJ, Wong GY, Potter CE, Gonzalez A, Rosen PP. 1992, Immunofluorescent monoclonal antibody (MAB) detection of breast cancer bone marrow micrometastases (BMM) in patients with unilateral invasive breast cancer: distribution by TNM stage. Breast Cancer Research and Treatment, 23:136

15. Osborne MP, Potter CE, Borgen PI, Wong GY, Lubin MB, Miller DG. 1992, Surveillance programs for women at increased risk of breast cancer due to family history in first degree relatives. Proceedings of the American Association for Cancer Research,11:147

16. McKinnon WMP, Borgen PI, Hoffman B, Potter C, Wong GY, Kinne DW, Osborne MP. 1992, Current management of male breast cancer: A review of 108 cases. Annals of Surgery, 215:451-459

17. Glicksman CA, Chaglassian TA, Kinne DW, Moore MP, Reichman BS, Potter CE, Osborne MP. 1991 Immediate reconstruction with tissue expansion and concurrent systemic adjuvant chemotherapy. Proceedings American Society for Plastic and Reconstructive Surgery.

18. Osborne MP, Wong GY, Cote RJ, Liu J, Potter C, Killackey D, Old LJ, Rosen PP. 1991, Breast cancer micrometastases in bone marrow: detection by fluorescein-labelled monoclonal antibodies predicts early relapse. Proceedings of the American Society of Clinical Oncology, 10:45

19. Osborne MP, Cote RJ, Asina S, Wong GY, Potter C, Killackey D, Rosen PP. 1990, Immunofluorescent monoclonal antibody detection of bone marrow micrometastases in patients with unilateral stages I-III invasive breast cancer. Breast Cancer Research and Treatment 16:194

20. Teaney DT, Potter CE, Gates L, Reed W, Reynolds E, Brown O. 1980, The well displayed electroglottograph-laryngeal mechanics in real-time. J. Acoustical Soc. Am. Suppl 1, April

21. Teaney DT, Potter CE, Gates L, Reed W, Reynolds E, Brown O. 1980, The laryngograph in singing I: general methods. J. Acoustical Soc. Am. Suppl 1, April

22. Teaney DT, Potter CE, Gates L, Reed W, Reynolds E, Brown O. 1980, The laryngograph in singing II: the "ring" in the professional voice. J. Acoustical Soc. Am. Suppl 1, April

23. Potter CE. 1980 , Sonic transliteration applied to descriptive music notation. Proceedings International. Computer Music Conference, 245

24 Potter CE, Teaney DT. The real-time power spectrum in instrument and voice teaching. 1979, J. Acoustical Soc. Am. Suppl 1, Fall

25. Cogan R, Potter CE, Teaney DT. 1979 The soundscore in composition and analysis. J. Acoustical Soc. Am. Suppl 1, Fall

CONTACT INFORMATION

Charles Potter
428 East 72nd Street
New York, NY 10021

Telephone: 212-794-4900 ext. 151
Fax: 212-794-4958
e-mail: cpotter@strang.org